HARBOR CAPITAL ADVISORS, INC.

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1039128 CHICAGO, IL

Position in TARS

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$2,054,202

+$275,605 QoQ

Shares Held

29,283

+34.8% QoQ

Ownership

0.068%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HARBOR CAPITAL ADVISORS, INC. holds $23,126,231 across 27 Biotechnology names. TARS ranks #3 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KYMR	Kymera Therapeutics, Inc.	33,948	$2,827,528
2	RYTM	Rhythm Pharmaceuticals, Inc.	30,353	$2,639,800
3	TARS	Tarsus Pharmaceuticals, Inc. This page	29,283	$2,054,202
4	VCEL	Vericel Corp	63,718	$2,049,808
5	HALO	Halozyme Therapeutics, Inc.	31,355	$2,026,473
6	RARE	Ultragenyx Pharmaceutical Inc.	83,196	$1,742,956
7	SRPT	Sarepta Therapeutics, Inc.	80,085	$1,742,649
8	AGIO	Agios Pharmaceuticals, Inc.	43,005	$1,454,859

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,054,202	29,283	+34.8%	Shares	Sole	2026-04-28
2025-12-31	$1,778,597	21,722	+39.4%	Shares	Sole	2026-01-20
2025-09-30	$926,394	15,588	-35.8%	Shares	Sole	2025-10-15
2025-06-30	$983,056	24,267	+16.8%	Shares	Sole	2025-07-09
2025-03-31	$1,066,852	20,768	-6.1%	Shares	Sole	2025-04-14
2024-12-31	$1,224,396	22,113	+22.1%	Shares	Sole	2025-01-10
2024-09-30	$595,473	18,105	+57.5%	Shares	Sole	2024-10-29
2024-06-30	$312,379	11,493	-1.1%	Shares	Sole	2024-07-09
2024-03-31	$422,387	11,620	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.